Category: Prescription Drugs
Global Prescription Drugs
-
Anti-Obesity Drugs
... CAGR of 8.7% over the analysis period 2024-2030. Prescription Drugs, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$4.9 Billion by the end of the analysis ... Read More
-
Prescription Drugs
... CAGR of 5.7% over the analysis period 2024-2030. Generic Drugsone of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$498.0 Billion by the end of the analysis period. ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end ... Read More
-
Acne Drugs
... CAGR of 6.9% over the analysis period 2024-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Animal Medication
... CAGR of 4.5% over the analysis period 2024-2030. Companion Animals Medication, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$20.7 Billion by the end of the ... Read More
-
Migraine Drugs
... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Anti-Infectives
... 6.2% over the analysis period 2024-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. Growth ... Read More
-
Human Reproductive Technologies
... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by ... Read More
-
e-Prescription Systems
... CAGR of 16.7% over the analysis period 2024-2030. e-Prescription Solutions, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$3.2 Billion by the end of the analysis ... Read More
-
E-Pharmacy Global Market Report 2025
... strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the most comprehensive ... Read More
-
Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033
... Inc.; Eli Lilly and Company; H. Lundbeck AS; Bayer AG Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical ... Read More
-
Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033
... Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc. Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; ... Read More
-
Global Acute Respiratory Distress Syndrome Treatment Market 2025-2029
... report on the acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Drugs for Malaria Competitive Landscape Professional Research Report 2025
... Plasmodium genus. These drugs include antimalarial agents like chloroquine, artemisinin-based combination therapies (ACTs), mefloquine, atovaquone-proguanil, and others. The choice of drug depends on the specific Plasmodium species causing the infection and its resistance patterns. Antimalarials ... Read More
-
Global Halal Pharmaceuticals Competitive Landscape Professional Research Report 2025
... permissible or lawful, and Halal pharmaceuticals adhere to specific guidelines to ensure that the ingredients, manufacturing processes, and overall composition align with Islamic principles. These pharmaceuticals are free from substances considered haram (forbidden), such as ... Read More
-
Global Ovarian Cancer Drugs Market - 2024-2032
... during the forecast period 2024-2031. Ovarian cancer is the growth of abnormal cancerous cells in the ovaries, fallopian tube, or peritoneum- the major parts of the woman’s reproductive system. Ovaries are made up of different ... Read More
-
Global Antipsychotic Drugs Market - 2025-2032
... forecast period 2025-2032. Antipsychotic medications are an important class of psychiatric drugs prescribed to manage psychosis, which includes symptoms such as delusions, hallucinations, and disorganized thinking. These medications are primarily used to treat conditions like ... Read More
-
Global Asthma Drugs Market - 2025 - 2032
... during the forecast period 2025-2032. Asthma is a prevalent, chronic inflammatory condition that affects millions of individuals worldwide. It often leads to unplanned healthcare visits and results in missed school and workdays. Asthma is characterized ... Read More
-
Global Pain Management Drugs Market - 2025-2033
... during the forecast period 2024-2032. Pain management drugs also called analgesics, are medications aimed at alleviating pain. These are classified into several categories which majorly include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, muscle relaxants, anticonvulsants, ... Read More
-
Global Drug Abuse Testing Market - 2025 - 2033
... of 5.3% during the forecast period 2025-2033. Drug abuse testing is a crucial process for detecting prescription drugs in a person's system, ensuring safety, compliance, and medical evaluation. It is used in workplace screening, forensic ... Read More
-
Global Antiplatelet Drugs Market - 2025 - 2032
... % during the forecast period 2025-2032. The global antiplatelet drugs market encompasses the pharmaceutical industry segment dedicated to medications that inhibit platelet aggregation, thereby reducing the risk of blood clot formation. These drugs are essential ... Read More
-
Global Hormone Replacement Therapy Market - 2024 - 2032
... of 6.1% during the forecast period 2024-2032. Hormone Replacement Therapy (HRT) is a treatment that involves the use of hormones to address symptoms linked to hormonal imbalances, particularly during menopause, as well as in conditions ... Read More
-
Global Diabetes Drugs Market - 2025 - 2032
... % during the forecast period 2025-2032. Diabetes is a chronic condition that arises when the pancreas either fails to produce sufficient insulin or when the body cannot effectively utilize the insulin it produces. Insulin is ... Read More
-
Global Incretin-Based Drugs Market - 2025 - 2032
... during the forecast period 2025-2032. Incretin-based drugs are a class of antidiabetic medications designed to mimic the effects of incretin hormones, which are naturally produced by the body to help regulate insulin secretion in response ... Read More
-
Bipolar Disorder Therapeutics Global Market Report 2025
... Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: AbbVie Inc.; Pfizer Inc.; Astellas Pharma Inc; AstraZeneca PLC; Bristol-Myers Squibb Bipolar Disorder Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and ... Read More
Research Assistance
